82 FR 25334 - Bulk Manufacturer of Controlled Substances Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 104 (June 1, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 104 (June 1, 2017)
| Page Range | 25334-25335 | |
| FR Document | 2017-11383 |
[Federal Register Volume 82, Number 104 (Thursday, June 1, 2017)] [Notices] [Pages 25334-25335] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-11383] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Registration ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices. ---------------------------------------------------------------------------------------------------------------- Company FR docket Published ---------------------------------------------------------------------------------------------------------------- Cody Laboratories, Inc................... 81 FR 61249 September 6, 2016. Alcami Wisconsin Corporation............. 81 FR 63219 September 14, 2016. Johnson Matthey, Inc..................... 81 FR 71767 October 18, 2016. Noramco, Inc............................. 82 FR 6645 January 19, 2017. Organix, Inc............................. 82 FR 8433 January 25, 2017. Mallinckrodt, LLC........................ 82 FR 13136 March 9, 2017. Siemens Healthcare Diagnostics, Inc...... 82 FR 13506 March 13, 2017. ---------------------------------------------------------------------------------------------------------------- The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies. [[Page 25335]] Dated: May 23, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017-11383 Filed 5-31-17; 8:45 am] BILLING CODE 4410-09-P
![25334 Federal Register / Vol. 82, No. 104 / Thursday, June 1, 2017 / Notices
violation of subsection (a)(1)(B) of (b) The respondents are the following deemed to constitute a waiver of the
section 337 in the importation into the entities alleged to be in violation of right to appear and contest the
United States, the sale for importation, section 337, and are the parties upon allegations of the complaint and this
or the sale within the United States after which the complaint is to be served: notice, and to authorize the
importation of certain magnetic tape Fujifilm Holdings Corporation, 7–3 administrative law judge and the
cartridges and components thereof by Akasaka 9-chome, Minato-ku, Tokyo Commission, without further notice to
reason of infringement of one or more of 107–0052, Japan. the respondent, to find the facts to be as
claims 1–19 of the ’596 patent; claims Fujifilm Corporation, 7–3 Akasaka 9- alleged in the complaint and this notice
1–6 and 8 of the ’501 patent; and claims chome, Minato-ku, Tokyo 107–0052, and to enter an initial determination
1–11 and 15–20 of the ’774 patent, and Japan. and a final determination containing
whether an industry in the United Fujifilm Media Manufacturing Co., such findings, and may result in the
States exists as required by subsection Ltd., 12–1 Ogimachi 2-chome, Odawara, issuance of an exclusion order or a cease
(a)(2) of section 337; Kanagawa 250–0001, Japan. and desist order or both directed against
(2) Pursuant to Commission Rule Fujifilm Holdings America the respondent.
210.50(b)(1), 19 CFR 210.50(b)(1), the Corporation, 200 Summit Lake Drive, By order of the Commission.
presiding administrative law judge shall Valhalla, NY 10595. Issued: May 26, 2017.
take evidence or other information and Fujifilm Recording Media U.S.A., Inc., Lisa R. Barton,
hear arguments from the parties and 45 Crosby Drive, Bedford, MA 01730– Secretary to the Commission.
other interested persons with respect to 1401.
the public interest in this investigation, [FR Doc. 2017–11307 Filed 5–31–17; 8:45 am]
as appropriate, and provide the (c) The Office of Unfair Import BILLING CODE 7020–02–P
Commission with findings of fact and a Investigations, U.S. International Trade
recommended determination on this Commission, 500 E Street SW., Suite
issue, which shall be limited to the 401, Washington, DC 20436; and
(4) For the investigation so instituted, DEPARTMENT OF JUSTICE
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1); the Chief Administrative Law Judge, Drug Enforcement Administration
(3) For the purpose of the U.S. International Trade Commission,
investigation so instituted, the following shall designate the presiding [Docket No. DEA–392]
are hereby named as parties upon which Administrative Law Judge.
Responses to the complaint and the Bulk Manufacturer of Controlled
this notice of investigation shall be
notice of investigation must be Substances Registration
served:
submitted by the named respondents in
(a) The complainants are:
accordance with section 210.13 of the ACTION: Notice of registration.
Sony Corporation, 1–7–1 Konan, Commission’s Rules of Practice and
Minato-ku, Tokyo 108–0075, Japan. Procedure, 19 CFR 210.13. Pursuant to SUMMARY: Registrants listed below have
Sony Storage Media Solutions 19 CFR 201.16(e) and 210.13(a), such applied for and been granted
Corporation, 1–7–1 Konan, Minato-ku, responses will be considered by the registration by the Drug Enforcement
Tokyo 108–0075, Japan. Commission if received not later than 20 Administration (DEA) as bulk
days after the date of service by the manufacturers of various classes of
Sony Storage Media Manufacturing
Commission of the complaint and the controlled substances.
Corporation, 3–4–1 Sakuragi, Tagajo,
Miyagi 985–0842, Japan. notice of investigation. Extensions of SUPPLEMENTARY INFORMATION: The
time for submitting responses to the companies listed below applied to be
Sony DADC US Inc., 1800 North registered as manufacturers of various
complaint and the notice of
Fruitridge Avenue, Terre Haute, IN basic classes of controlled substances.
investigation will not be granted unless
47804. Information on previously published
good cause therefor is shown.
Sony Latin America Inc., 5201 Blue Failure of a respondent to file a timely notices is listed in the table below. No
Lagoon Drive, Suite 400, Miami, FL response to each allegation in the comments or objections were submitted
33126. complaint and in this notice may be for these notices.
Company FR docket Published
Cody Laboratories, Inc ................................................................................................................................... 81 FR 61249 September 6, 2016.
Alcami Wisconsin Corporation ....................................................................................................................... 81 FR 63219 September 14, 2016.
Johnson Matthey, Inc ..................................................................................................................................... 81 FR 71767 October 18, 2016.
Noramco, Inc .................................................................................................................................................. 82 FR 6645 January 19, 2017.
Organix, Inc .................................................................................................................................................... 82 FR 8433 January 25, 2017.
Mallinckrodt, LLC ........................................................................................................................................... 82 FR 13136 March 9, 2017.
Siemens Healthcare Diagnostics, Inc ............................................................................................................ 82 FR 13506 March 13, 2017.
The DEA has considered the factors in investigated each of the company’s Therefore, pursuant to 21 U.S.C.
21 U.S.C. 823(a) and determined that maintenance of effective controls 823(a), and in accordance with 21 CFR
mstockstill on DSK30JT082PROD with NOTICES
the registration of these registrants to against diversion by inspecting and 1301.33, the DEA has granted a
manufacture the applicable basic classes testing each company’s physical registration as a bulk manufacturer to
of controlled substances is consistent security systems, verifying each the above listed companies.
with the public interest and with United company’s compliance with state and
States obligations under international local laws, and reviewing each
treaties, conventions, or protocols in company’s background and history.
effect on May 1, 1971. The DEA
VerDate Sep<11>2014 21:19 May 31, 2017 Jkt 241001 PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 E:\FR\FM\01JNN1.SGM 01JNN1](https://thefederalregister.org/doc/82_FR_25438/page/1.svg)
![Federal Register / Vol. 82, No. 104 / Thursday, June 1, 2017 / Notices 25335
Dated: May 23, 2017. The company plans to manufacture manufacturers, distributors, dispensers,
Louis J. Milione, small quantities of the listed controlled importers, and exporters of controlled
Assistant Administrator. substance in bulk for distribution to its substances (other than final orders in
[FR Doc. 2017–11383 Filed 5–31–17; 8:45 am] customers. connection with suspension, denial, or
BILLING CODE 4410–09–P Dated: May 23, 2017. revocation of registration) has been
Louis J. Milione, redelegated to the Assistant
Assistant Administrator.
Administrator of the DEA Diversion
DEPARTMENT OF JUSTICE Control Division (‘‘Assistant
[FR Doc. 2017–11385 Filed 5–31–17; 8:45 am]
Administrator’’) pursuant to section 7 of
BILLING CODE 4410–09–P
Drug Enforcement Administration 28 CFR part 0, appendix to subpart R.
[Docket No. DEA–392] In accordance with 21 CFR
DEPARTMENT OF JUSTICE 1301.34(a), this is notice that on April
Bulk Manufacturer of Controlled 6, 2017, Cerilliant Corporation, 811
Substances Application: Chemtos, Drug Enforcement Administration Paloma Drive, Suite A, Round Rock,
LLC Texas 78665–2402 applied to be
[Docket No. DEA–392]
registered as an importer of U–47700
ACTION: Notice of application. (3,4-dichloro-N-[2-
Importer of Controlled Substances
Application: Cerilliant Corporation dimethylamino)cyclohexyl]-N-
DATES: Registered bulk manufacturers of methylbenzamide) (9547), a basic class
the affected basic class, and applicants ACTION: Notice of application. of controlled substance listed in
therefore, may file written comments on schedule I.
or objections to the issuance of the DATES: Registered bulk manufacturers of The company plans to import small
proposed registration in accordance the affected basic classes, and quantities of the listed controlled
with 21 CFR 1301.33(a) on or before July applicants therefore, may file written substance for the manufacture of
31, 2017. comments on or objections to the analytical reference standards and
ADDRESSES: Written comments should issuance of the proposed registration in distribution to their research and
be sent to: Drug Enforcement accordance with 21 CFR 1301.34(a) on forensic customers.
Administration, Attention: DEA Federal or before July 3, 2017]. Such persons
Dated: May 25, 2017.
Register Representative/DRW 8701 may also file a written request for a
hearing on the application pursuant to Louis J. Milione,
Morrissette Drive, Springfield, Virginia
22152. 21 CFR 1301.43 on or before July 3, Assistant Administrator.
2017. [FR Doc. 2017–11387 Filed 5–31–17; 8:45 am]
SUPPLEMENTARY INFORMATION: The
BILLING CODE 4410–09–P
Attorney General has delegated his ADDRESSES: Written comments should
authority under the Controlled be sent to: Drug Enforcement
Substances Act to the Administrator of Administration, Attention: DEA Federal
DEPARTMENT OF JUSTICE
the Drug Enforcement Administration Register Representative/DRW, 8701
(DEA), 28 CFR 0.100(b). Authority to Morrissette Drive, Springfield, Virginia Drug Enforcement Administration
exercise all necessary functions with 22152. All requests for hearing must be
respect to the promulgation and sent to: Drug Enforcement
[Docket No. DEA–392]
implementation of 21 CFR part 1301, Administration, Attn: Administrator,
incident to the registration of 8701 Morrissette Drive, Springfield, Importer of Controlled Substances
manufacturers, distributors, dispensers, Virginia 22152. All requests for hearing Registration
importers, and exporters of controlled should also be sent to: (1) Drug
substances (other than final orders in Enforcement Administration, Attn: ACTION: Notice of registration.
connection with suspension, denial, or Hearing Clerk/LJ, 8701 Morrissette
revocation of registration) has been Drive, Springfield, Virginia 22152; and SUMMARY: Registrants listed below have
redelegated to the Assistant (2) Drug Enforcement Administration, applied for and been granted
Administrator of the DEA Diversion Attn: DEA Federal Register registration by the Drug Enforcement
Control Division (‘‘Assistant Representative/DRW, 8701 Morrissette Administration (DEA) as importers of
Administrator’’) pursuant to section 7 of Drive, Springfield, Virginia 22152. various classes of schedule I or II
28 CFR part 0, appendix to subpart R. SUPPLEMENTARY INFORMATION: The controlled substances.
In accordance with 21 CFR Attorney General has delegated his SUPPLEMENTARY INFORMATION: The
1301.33(a), this is notice that on July 5, authority under the Controlled companies listed below applied to be
2016, Chemtos, LLC, 14101 W. Highway Substances Act to the Administrator of registered as importers of various basic
290, Building 2000B, Austin, Texas the Drug Enforcement Administration classes of controlled substances.
78737–9331 applied to be registered as (DEA), 28 CFR 0.100(b). Authority to Information on previously published
a bulk manufacturer for 3,4- exercise all necessary functions with notices is listed in the table below. No
Methylenedioxymethamphetamine respect to the promulgation and comments or objections were submitted
(7405), a basic class of controlled implementation of 21 CFR part 1301, and no requests for hearing were
substance listed in schedule I. incident to the registration of submitted for these notices.
mstockstill on DSK30JT082PROD with NOTICES
Company FR docket Published
Chattem Chemicals, Inc ................................................................................................................................. 81 FR 62177 September 8, 2016.
Anderson Brecon, Inc .................................................................................................................................... 81 FR 71766 October 18, 2016.
Hospira ........................................................................................................................................................... 82 FR 11241 February 21, 2017.
Myoderm ........................................................................................................................................................ 82 FR 13134 March 9, 2017.
Meridian Medical Technologies ..................................................................................................................... 82 FR 13135 March 9, 2017.
VerDate Sep<11>2014 18:32 May 31, 2017 Jkt 241001 PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 E:\FR\FM\01JNN1.SGM 01JNN1](https://thefederalregister.org/doc/82_FR_25438/page/2.svg)
Document Created: 2017-06-01 03:05:36
Document Modified: 2017-06-01 03:05:36
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 82 FR 25334 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR